We partner with innovator and generic companies using our high-quality infrastructure and a global network of clinical trial sites, to launch novel therapies and new products for patients worldwide. Building on our strong foundation in global oncology studies, we offer solutions across multiple therapeutic domains, accelerating pipelines through AI and advanced real-world data capabilities.